Literature DB >> 25924761

Dysregulation of serum gamma interferon levels in vascular chronic Q Fever patients provides insights into disease pathogenesis.

Jeroen L A Pennings1, Marjolein N T Kremers2, Hennie M Hodemaekers3, Julia C J P Hagenaars4, Olivier H J Koning4, Nicole H M Renders5, Mirjam H A Hermans6, Arja de Klerk3, Daan W Notermans7, Peter C Wever5, Riny Janssen3.   

Abstract

A large community outbreak of Q fever occurred in the Netherlands in the period 2007 to 2010. Some of the infected patients developed chronic Q fever, which typically includes pathogen dissemination to predisposed cardiovascular sites, with potentially fatal consequences. To identify the immune mechanisms responsible for ineffective clearance of Coxiella burnetii in patients who developed chronic Q fever, we compared serum concentrations of 47 inflammation-associated markers among patients with acute Q fever, vascular chronic Q fever, and past resolved Q fever. Serum levels of gamma interferon were strongly increased in acute but not in vascular chronic Q fever patients, compared to past resolved Q fever patients. Interleukin-18 levels showed a comparable increase in acute as well as vascular chronic Q fever patients. Additionally, vascular chronic Q fever patients had lower serum levels of gamma interferon-inducible protein 10 (IP-10) and transforming growth factor β (TGF-β) than did acute Q fever patients. Serum responses for these and other markers indicate that type I immune responses to C. burnetii are affected in chronic Q fever patients. This may be attributed to an affected immune system in cardiovascular patients, which enables local C. burnetii replication at affected cardiovascular sites.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25924761      PMCID: PMC4446408          DOI: 10.1128/CVI.00078-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  35 in total

1.  Intractable Q fever treated with recombinant gamma interferon.

Authors:  Y Morisawa; H Wakiguchi; T Takechi; T Kurashige; H Nagaoka
Journal:  Pediatr Infect Dis J       Date:  2001-05       Impact factor: 2.129

2.  Histological characteristics of the abdominal aortic wall in patients with vascular chronic Q fever.

Authors:  Julia C J P Hagenaars; Olivier H J Koning; Ronald F F van den Haak; Bart A N Verhoeven; Nicole H M Renders; Mirjam H A Hermans; Peter C Wever; Robert Jan van Suylen
Journal:  Int J Exp Pathol       Date:  2014-06-23       Impact factor: 1.925

3.  IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking.

Authors:  Jennifer H Dufour; Michelle Dziejman; Michael T Liu; Josephine H Leung; Thomas E Lane; Andrew D Luster
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

Review 4.  Interleukin-18, a proinflammatory cytokine.

Authors:  C A Dinarello
Journal:  Eur Cytokine Netw       Date:  2000-09       Impact factor: 2.737

5.  Immunomodulatory role of endogenous interleukin-18 in gamma interferon-mediated resolution of replicative Legionella pneumophila lung infection.

Authors:  J K Brieland; C Jackson; S Hurst; D Loebenberg; T Muchamuel; R Debets; R Kastelein; T Churakova; J Abrams; R Hare; A O'Garra
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Use of genetic profiling in leprosy to discriminate clinical forms of the disease.

Authors:  Joshua R Bleharski; Huiying Li; Christoph Meinken; Thomas G Graeber; Maria-Teresa Ochoa; Masahiro Yamamura; Anne Burdick; Euzenir N Sarno; Manfred Wagner; Martin Röllinghoff; Thomas H Rea; Marco Colonna; Steffen Stenger; Barry R Bloom; David Eisenberg; Robert L Modlin
Journal:  Science       Date:  2003-09-12       Impact factor: 47.728

7.  Cloning of a new cytokine that induces IFN-gamma production by T cells.

Authors:  H Okamura; H Tsutsi; T Komatsu; M Yutsudo; A Hakura; T Tanimoto; K Torigoe; T Okura; Y Nukada; K Hattori
Journal:  Nature       Date:  1995-11-02       Impact factor: 49.962

Review 8.  Legionella and Legionnaires' disease: 25 years of investigation.

Authors:  Barry S Fields; Robert F Benson; Richard E Besser
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Reduced interferon-gamma release in patients recovered from Legionnaires' disease.

Authors:  K D Lettinga; S Weijer; P Speelman; J M Prins; T Van Der Poll; A Verbon
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

Review 10.  Interferon-gamma, the activated macrophage, and host defense against microbial challenge.

Authors:  H W Murray
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

View more
  1 in total

1.  Natural genetic variation in Drosophila melanogaster reveals genes associated with Coxiella burnetii infection.

Authors:  Rosa M Guzman; Zachary P Howard; Ziying Liu; Ryan D Oliveira; Alisha T Massa; Anders Omsland; Stephen N White; Alan G Goodman
Journal:  Genetics       Date:  2021-03-31       Impact factor: 4.562

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.